These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16901660)

  • 21. Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists.
    Pedersen AT; Iversen OE; Løkkegaard E; Mattsson LA; Milsom I; Nilsen ST; Ottesen B; Moen MH
    Acta Obstet Gynecol Scand; 2007; 86(12):1490-5. PubMed ID: 18027116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine's implications for women's health and survey of obstetrician-gynecologists' caffeine knowledge and assessment practices.
    Anderson BL; Juliano LM; Schulkin J
    J Womens Health (Larchmt); 2009 Sep; 18(9):1457-66. PubMed ID: 19708805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brief report: attitudes toward hormone therapy after the Women's Health Initiative: a comparison of internists and gynecologists.
    Brett AS; Carney PI; McKeown RE
    J Gen Intern Med; 2005 May; 20(5):416-8. PubMed ID: 15963163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Provider management of menopause after the findings of the Women's Health Initiative.
    Rolnick SJ; Jackson J; Kopher R; Defor TA
    Menopause; 2007; 14(3 Pt 1):441-9. PubMed ID: 17318028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany.
    Heitmann C; Greiser E; Dören M
    Menopause; 2005; 12(4):405-11. PubMed ID: 16037755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
    Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
    Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impacts on clinical decision making - changing hormone therapy management after the WHI.
    Sturmberg JP; Pond DC
    Aust Fam Physician; 2009 Apr; 38(4):249-51, 253-5. PubMed ID: 19350076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
    Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey.
    Wang Y; Yang X; Li X; He X; Zhao Y
    Menopause; 2014 Nov; 21(11):1190-6. PubMed ID: 24736196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone therapy prescription among physicians in France and Quebec.
    Ringa V; Légaré F; Dodin S; Norton J; Godin G; Bréart G
    Menopause; 2004; 11(1):89-97. PubMed ID: 14716188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitude of German gynecologists towards prescribing HRT before and after the WHI study.
    Buhling KJ; von Studnitz FS; Jantke A; Eulenburg C; Mueck AO
    Climacteric; 2012 Aug; 15(4):326-31. PubMed ID: 22200104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation.
    Ringa V; Varnoux N; Piault S; Bréart G
    Fertil Steril; 2005 Jun; 83(6):1771-9. PubMed ID: 15950650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eating disorders and obstetric-gynecologic care.
    Leddy MA; Jones C; Morgan MA; Schulkin J
    J Womens Health (Larchmt); 2009 Sep; 18(9):1395-401. PubMed ID: 19743910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Swedish gynecologists' and general practitioners' views on the climacteric period: knowledge, attitudes and management strategies.
    Andersson K; Pedersen AT; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 1998 Oct; 77(9):909-16. PubMed ID: 9808379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy: a survey of Ontario physicians' prescribing practices.
    Elinson L; Cohen MM; Elmslie T
    CMAJ; 1999 Sep; 161(6):695-8. PubMed ID: 10513275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why are physicians reluctant to use estrogens for anything--or do they prefer 'PROFOX'?
    Studd J
    Menopause Int; 2009 Jun; 15(2):52-4. PubMed ID: 19465668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.
    Huang WF; Tsai YW; Hsiao FY; Liu WC
    BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in practice since the publication in 2007 of further results from the Women's Health Initiative and the Million Women Study.
    Cust MP
    Menopause Int; 2007 Dec; 13(4):141-3. PubMed ID: 18088523
    [No Abstract]   [Full Text] [Related]  

  • 40. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.
    Gerend MA; Aiken LS; Erchull MJ; Lapin A
    Prev Med; 2006 Sep; 43(3):158-64. PubMed ID: 16750263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.